Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories launches Metaxalone Tablets in US market
>>
Dr. Reddy's launches Bupropion Hydrochloride Extended-Release Tablets in US
>>
Clarification sought from Dr Reddys Laboratories
>>
Dr. Reddy’s, Vivus settle long-pending patent litigation for Qsymia
>>
Dr. Reddy’s Laboratories trades in green on the bourses
>>
Dr. Reddy’s to reintroduce back pain-reliever Doan’s in US
>>
Dr. Reddy’s faces class action suit in US District Court
>>
Dr. Reddy’s Lab launches Cefixime for Oral Suspension in US markets
>>
Dr. Reddy's Laboratories informs about company updates
>>
Dr. Reddy’s Laboratories trades with traction on the bourses
<<
<
86
87
88
...145
>
>>